feed,title,long_url,short_url
SSRN,"Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study",https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4070408,
